Pembrolizumab and Disitamab Vedotin in HER2-expressing Metastatic Colorectal Cancer

NCT05333809 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: Pembrolizumab
DRUG: Disitamab vedotin

Sponsor

Shanghai Zhongshan Hospital